Impaired cell-mediated immunity in focal glomerular sclerosis

Area of Science:

• Immunology
• Nephrology

Background:

• Focal glomerular sclerosis (FGS) is a kidney disease affecting the glomeruli.
• Cell-mediated immunity (CMI) plays a crucial role in immune responses.
• Understanding CMI in FGS is important for disease pathophysiology.

Purpose of the Study:

• To evaluate cell-mediated immunity (CMI) in patients with focal glomerular sclerosis (FGS).
• To compare CMI parameters in FGS patients with nephrotic syndrome (NS) to those without NS and healthy controls.

Main Methods:

• Assessed delayed skin reactivity to purified protein derivative.
• Measured circulating lymphocytes and lymphocyte cell-surface markers (rosettes).
• Evaluated functional markers: mitogenic responses to concanavalin A and phytohemagglutinin.

Main Results:

• FGS patients with nephrotic syndrome (NS) showed significantly depressed CMI.
• This included decreased lymphocyte responses to mitogens and impaired delayed hypersensitivity.
• A decreased proportion of T lymphocytes was observed in FGS patients with NS.

Conclusions:

• The majority of FGS patients with NS exhibit impaired cell-mediated immunity.
• These CMI alterations may be significant in the pathophysiology of FGS.
• CMI levels in FGS patients in remission or chronic glomerulonephritis did not differ from controls.